UNH241129C610000
- 1.97
- -0.33-14.35%
UnitedHealth Newsroom
Catalyst Watch: November Jobs, OPEC+ Meeting, Marvell, Salesforce Earnings
UnitedHealth Group Incorporated's (NYSE:UNH) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
The Trump economic team may have internal discord, and the key agenda still needs the "understanding king" to make the final decision!
Analysts state that the Trump team's characterization of the economic policy as 'the opponent team' is almost accurate, and the strong opposition between Besant and Lutnik has been publicly reported.
'Bunker' and 'Booster' Stocks in the U.S. – Which Would Perform Better in a Downturn Vs. Upturn?
Barclays raised UnitedHealth's target price to $655.
Gelonghui, November 27: Barclays has raised the target price of unitedhealth from $603 to $655, maintaining the 'shareholding' rating. (Gelonghui)
UnitedHealth, 3M Share Gains Contribute To Dow's 119-Point Jump
UnitedHealth Is Maintained at Overweight by Barclays
UnitedHealth Group Analyst Ratings
Morgan Stanley Maintains UnitedHealth(UNH.US) With Buy Rating, Maintains Target Price $610
UnitedHealth's Strategic Outlook Reinforces Buy Rating Amidst Positive Medicare Insights and Growth Visibility
Barclays Maintains UnitedHealth(UNH.US) With Buy Rating, Raises Target Price to $655
UnitedHealth Group (UNH) Ascends But Remains Behind Market: Some Facts to Note
Today's Analyst Rating | UnitedHealth Price Target Raised to $655 by RBC Capital, Citi Upgrades Chevron to Buy
Nov 26, Wall Street analysts have updated their stock ratings today including $UnitedHealth(UNH.US)$ and $Chevron(CVX.US)$.
RBC Capital Maintains UnitedHealth(UNH.US) With Buy Rating, Raises Target Price to $655
Recalculation Ahead: Implications of UnitedHealth's Win Against CMS
UnitedHealth Group to Host 2024 Investor Conference
Biden Proposes Medicare, Medicaid Coverage of Obesity Drugs
White House Proposes Big Expansion of Medicare, Medicaid Coverage of Obesity Drugs
Express News | UnitedHealth : RBC Raises Target Price to $655 From $595
Humana Rises After Favorable Ruling Peer UnitedHealth Star Rating